Google-backed Isomorphic raises $2.1 billion to scale AI-driven drug discovery

Short summary

Isomorphic Labs, backed by Google, raised $2.1 billion led by Thrive Capital to scale its AI-powered drug discovery engine. Clinical trials are expected to begin in late 2026. The funding signals strong market validation for AI-driven pharmaceutical research.

• •$2.1B funding round led by Thrive Capital for AI drug discovery
• •Clinical trials anticipated by late 2026
• •Validates market demand for AI in pharmaceutical R&D

Generated with AI, which can make mistakes.